Hummingbird News Desk
NEW DELHI, 13 MAY: The Union health ministry on Thursday increased the time gap between two doses of Covishield vaccine to 12 to 16 weeks from the earlier 6 to 8 weeks based on the recommendation of the Covid working committee chaired by Dr N K Arora.
The decision comes at a time when India is facing a shortage of doses of both Covishield and Covaxine, particularly after expanding the immunization drive to include everyone above of the age of 18.
The government, however, clarified the decision has been taken based on real-life evidence, especially from the UK.
“Based on the available real-life evidences, particularly from UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of COVISHIELD vaccine. No change in interval of COVAXIN vaccine doses was recommended,” a release from the government stated.
The recommendation of the COVID Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr V K Paul, Member (Health) Niti Aayog in its meeting on 12th May 2021.
The Union Ministry of Health and Family Welfare has also accepted this recommendation of the COVID Working Group for extension of the gap between the first and second doses of COVISHIELD vaccine to 12 -16 weeks.
The COVID Working Group comprises of the following members:
- Dr N K Arora- Director, INCLEN Trust
- Dr Rakesh Agarwal, Director and dean, JIPMER, Puducherry
- Dr Gagandeep Kang, professor, Christian Medical College, Vellore
- Dr J P Mulliyal, Retd professor, Christian Medical College, Vellore
- Dr Naveen Khanna, Group Leader, International Centre For Genetic Engineering And Biotechnology (ICGEB), JNU, New Delhi
- Dr Amulya Panda, Director, National Institute of Immunology, New Delhi
- Dr V G Somani, Drugs Controller General of India (DCGI), Govt of India
Tags: #CovishieldVaccine #Unite2FightCorona #COVID19 #COVAXIN
